Objectives After finishing this article, readers should be able to:
1. Discuss the risk factors for acquisition of Neisseria gonorrhoeae.
Recognize the different clinical manifestations of gonococcal infections.
3. Understand the importance of following current treatment recommendations for N gonorrhoeae.
Epidemiology
Neisseria gonorrhoeae is an oxidase-positive diplococcus that grows in warm, moist environments. The optimal temperature for growth is 35°to 37°C. (2) Typically an intracellular organism, N gonorrhoeae cannot live outside of its human host and is differentiated from other species of Neisseria by its ability to ferment glucose instead of other carbohydrates. The organism survives and replicates within host macrophages after phagocytosis but is killed by polymorphonuclear leukocytes. N gonorrhoeae is shed in exudates and secretions transmitted through intimate contact, such as sexual contact or vaginal delivery. N gonorrhoeae is the second most commonly occurring reportable sexually transmitted disease (STD), or sexually transmitted infection (STI; currently the more accepted term), after Chlamydia trachomatis. Incidence of gonococcal infections is estimated at 700,000 new cases in the United States per year. (1) Although incidence rates had declined to historically low levels since 1998, statistics from 2010 show a slight increase in the amount of new cases reported. (3) Adolescents (15-19 years of age) and young adults (20-24 years of age) account for the majority of new cases reported each year. However, ethnic minority groups (African Americans, Hispanics, and Native Americans) continue to account for a disproportionate number of cases. Males and females continue to account for an equal amount of new cases per year, and the Southeastern region of the United States remains the most affected geographic region. (4) Additionally, men who have sex with men (MSM) comprise a population experiencing increasing rates of infection. The STD Surveillance Network noted an increased prevalence of gonococcal infections in MSM infected with human immunodeficiency virus (HIV) compared to MSM not infected with HIV. (3) Any sexually active person can be infected with N gonorrhoeae. Behavioral factors predisposing adolescents and young adults to infection include (1) having multiple or new sex partners; (2) inconsistent, incorrect, or no condom use; and (3) lack of screening by health care providers. Additionally, adolescent females are biologically predisposed to infection due to the larger number of columnar epithelial cells that are exposed on the ectocervix during the teenage years.
Pathogenesis
N gonorrhoeae invades mucosal and glandular surfaces lined with columnar or cuboidal, noncornified epithelium, resulting in a local inflammatory response that involves recruitment of polymorphonuclear leukocytes and macrophages.
Virulence is mediated by several distinct characteristics associated with the bacterial outer cell wall membrane. The endotoxin activity of lipooligosaccharides assists in cytotoxicity and acts as a target for the bactericidal antibody. In turn, opacity-associated proteins are thought to aid in the binding to human cells, and expression of variant pili helps the bacteria adhere to tissues, thereby protecting the bacteria from phagocytosis.
Clinical Aspects Neonates
Gonococcal infections can occur throughout the entire lifespan of the human host. Neonates exposed to infected exudate during vaginal delivery can develop ophthalmia neonatorum, scalp abscesses, or disseminated disease. Characterized by purulent conjunctivitis, ophthalmia neonatorum presents 1 to 4 days after birth. All neonates who have conjunctivitis should have exudates cultured and tested for antibiotic susceptibility. Examination of exudateyielding intracellular gram-negative diplococci should raise suspicion for gonococcal ophthalmia, and presumptive treatment should be started after collecting appropriate cultures. Lack of prevention or delay in treatment of ophthalmia neonatorum can lead to corneal ulceration, globe rupture, and blindness. Currently, prophylaxis with erythromycin (0.5%) ophthalmic ointment is recommended for all newborn infants regardless of method of delivery. (1) 
Prepubertal Children
Acquisition of gonococcal infections during childhood occurs typically via sexual abuse; but, rarely, infections can be acquired through household exposure to affected caretakers or through childhood sexual play. Any child diagnosed as having gonorrhea should be evaluated for sexual abuse. Providers should refer any affected child to local Child Protection Service agency and other appropriate authorities, and specifically trained and experienced professionals should do the sexual abuse evaluation.
Gonococcal infections in children can occur in the pharynx, the rectum, and most commonly, the vagina. Because N gonorrhoeae can invade the thin noncornified epithelium of the vagina in prepubertal girls, gonococcal infections of the vagina are symptomatic and are characterized by purulent vaginal discharge, vaginitis, and an erythematous, swollen vulva.
Adolescents and Adults
Infections in adolescents may be either symptomatic or asymptomatic and therefore may be more difficult to diagnosis without proper screening. (Table 1 ) Infections in males are more likely to be symptomatic than those in females, but the appearance of symptoms may be delayed for weeks. Typical infections in males cause urethritis, proctitis, pharyngitis, and. Infection in females typically causes cervicitis, urethritis, proctitis, menometrorrhagia, pharyngitis, PID, perihepatitis, and DGI. Gonococcal infections in postpubertal females are commonly asymptomatic. Consequently, PID and DGI occur more often in females and probably develop from a spread of infection into the upper genital tract that is related to delay in diagnosis and treatment.
Pharyngitis
An overwhelming majority of pharyngeal gonococcal infections are asymptomatic. However, if symptomatic, the most common symptoms associated with infection are sore throat, fever, and cervical adenopathy. Patients who have a history of penile-oral contact are at increased risk for throat infection. Diagnosis of pharyngitis from 
Disseminated Gonococcal Infection
Disseminated disease typically is characterized by fever, arthritis, and rash. Occurring more frequently in females than males, it is thought that DGI is associated often with persistent asymptomatic infection, which results in delayed diagnosis and delayed treatment. In addition, females are at risk also during menstruation, pregnancy, and the postpartum period because of maximal endocervical shedding and decreased bactericidal activity of cervical mucus. (2) Two common classifications of DGI are tenosynovitisdermatitis syndrome and suppurative arthritis syndrome. Tenosynovitis-dermatitis, the more common, is characterized by fever, chills, skin lesions, and polyarthralgia, which primarily affects the hands and fingers. Monoarticular arthritis is the predominant manifestation of suppurative arthritis syndrome. (2) Skin manifestations of DGI present as hemorrhagic or vesiculopapular lesions. Frequently, these lesions are painful and appear on palmar and plantar surfaces. Twenty to 30 percent of these lesions may contain gonococci.
Less common manifestations of DGI include acute endocarditis, pericarditis, and meningitis. In cases of suspected DGI, cultures of blood, pharynx, rectum, urethra, cervix, and synovial fluid (if involved) should be collected. An elevated peripheral white blood cell count and increased erythrocyte sedimentation rate commonly occur.
Screening and Diagnostic Methods
Initial screening for suspected STIs such as gonorrhea begins with performing an appropriate history. A proper sexual history, including questions about high-risk behaviors and sites of sexual contact, must be obtained to direct laboratory screening to the appropriate anatomic site. Those inexperienced with taking a sexual history should refer to the CDC website (http://www.cdc.gov/ std/treatment/SexualHistory.pdf).
Because the clinical manifestations of gonococcal infections can mimic, or even coincide with, other infections such as chlamydial infection, bacterial vaginosis, and trichomoniasis, it is important to appropriately distinguish gonococcal infections from these other entities. Furthermore, untreated gonococcal disease can have complications that produce significant morbidity and mortality.
Specific diagnostic testing for gonorrhea consists of culture, nucleic hybridization tests, and nucleic acid amplification tests (NAATs). Culture can be performed on selective (eg, Thayer-Martin) or nonselective (eg, chocolate agar) media. Because of the limitation of genital specimensendocervical swab specimens in females and urethral swab specimens in males-culture and nucleic hybridization tests are not used as commonly as NAATs, which allow for the widest variety of specimen types: endocervical swabs, vaginal swabs, urethral swabs, and urine. Rectal swabs even may be processed in some laboratories. In addition, NAATs demonstrate high specificity and sensitivity and may be considered as less invasive and easier to perform (urine and vaginal specimens). Patient-collected vaginal swabs have demonstrated similar specificity and improved sensitivity compared with provider-collected swabs. Gram stain may be used to diagnose urethritis in males, as stated above, but should not be used to rule out gonorrhea in symptomatic individuals.
Cultures must be obtained in affected children because of legal implications and concerns for antibiotic resistance and antimicrobial susceptibility. Cultures must be performed as well on nongenital specimens from the rectum, pharynx, and conjunctiva.
Current recommendations advocate annual screening of sexually active adolescents for chlamydial infection and gonorrhea. Adolescents at higher risk, such as those with multiple partners or a history of STI, should be screened for both infections every 6 months. (1) Additionally, clinicians should recommend routine HIV and syphilis screening to all patients at increased risk for these infections. This group includes adolescents who seek screening for STIs, MSM, and those who exchange sex for money or drugs. (6,7) Clinicians should report STI cases in accordance with local and state requirements. Gonorrhea, along with syphilis, chlamydial infection, chancroid, HIV infection, and AIDS are reportable diseases in every state. (1)
Management
The largest hurdle in the treatment of gonococcal infections is the increase in multidrug-resistant strains. In 2007, quinolones were no longer recommended for the treatment of gonorrhea because of drug resistance. (8) In 2010, the preferred management of uncomplicated infections became intramuscular injection of ceftriaxone rather than oral administration of a thirdgeneration cephalosporin. (1) Ceftriaxone produces a higher and more sustained bactericidal level than cefixime. Ceftriaxone also has remained the preferred treatment for pharyngitis caused by N gonorrhoeae.
In August 2012, the CDC updated treatment guidelines for gonorrhea and no longer recommends oral cephalosporins as routine treatment for gonococcal infections. (9) This recommendation stems from declining effectiveness of infectious diseases gonococcal infections cefixime. Currently, combination therapy of ceftriaxone with either doxycycline or azithromycin is the recommended treatment for uncomplicated genital, rectal, and pharyngeal infections for two reasons: (1) to provide cotreatment of C trachomatis infection and (2) to assist in preventing further drug resistance because gonococci are susceptible to both drugs. (1) Cefixime, in combination therapy, may be used only if ceftriaxone is not available; however, a test of cure is recommended 1 week after treatment with cefixime. (8) Further efforts are being made to curb this increasing drug resistance. Table 3 lists the current recommendations for treatment of uncomplicated N gonorrhoeae in older children, adolescents, and adults according to the CDC.
Ceftriaxone is also the mainstay of treatment for infections in neonates, prepubertal children, and patients who have DGI or other complicated forms of gonococcal infection. Neonates with suspected ophthalmia neonatorum should receive one dose of ceftriaxone (25-50 mg/kg, intravenously or intramuscularly, not to exceed 125 mg) and should undergo frequent eye irrigations with saline solution until the discharge is gone. Neonates with disseminated infections, such as arthritis and septicemia, should be treated for 7 days with ceftriaxone, and neonates with meningitis should be treated for 10 to 14 days.
Management of prepubertal children is dependent on weight and age. Prepubertal children who weigh less than 45 kg and have uncomplicated gonococcal disease should be treated with 125 mg of ceftriaxone, and those above 45 kg should be treated with the adult dose. For children who weigh less than 45 kg and have DGI, treatment should consist of 50 mg/kg of ceftriaxone for 7 days, and the treatment of children above 45 kg or older than 8 years should consist of 1 g of ceftriaxone for 7 days. Meningitis should be treated for 10 to 14 days and endocarditis for 28 days with ceftriaxone. Further details on these therapies can be found in Red Book: 2012 Report of the Committee on Infectious Diseases. (10) Readers are urged to consult Red Book for complete management of gonococcal infection occurring in these special circumstances, which often requires the addition of a macrolide antibiotic.
Empiric management of sex partners must be undertaken to prevent reinfection and to stop further transmission. Counseling for the use of barrier protection methods (male latex condom) during all types of sexual contact also should be undertaken to prevent the spread of disease. Current recommendations require evaluation and treatment for both N gonorrhoeae and C trachomatis infection for all sexual partners of patients within 60 days of onset of symptoms or diagnosis. In patients whose last intercourse was greater than 60 days before the onset of symptoms or diagnosis, the most recent sexual partner should be treated.
When treatment of a sexual partner cannot be ensured or is unlikely, clinicians should consider expedited partner therapy (EPT). In EPT, the practitioner provides the partners of the infected patient with a prescription or medication for treatment of infection without an evaluation or examination. Currently, not all states allow this treatment, and clinicians should check the legal status of EPT in their jurisdictions. (11) Abstinence from sexual contact is recommended until therapy is completed and the signs and symptoms have resolved. 
Summary
• Gonococcal infections commonly are asymptomatic, especially in females.
• Clinicians miss opportunities to identify and treat infections because of the lack of symptoms and suboptimal screening, which allow for disease transmission.
Based on strong research evidence:
• The United States Preventative Services Task infectious diseases gonococcal infections
